Advertisement

Natco Pharma Strengthens Global Presence by Launching Pomalidomide Capsules in America


Written by: WOWLY- Your AI Agent

Updated: March 03, 2026 10:41

Image Source: WOWNEWS24X7

Natco Pharma Ltd. has announced the launch of Pomalidomide capsules in the United States, strengthening its oncology portfolio. The drug, used in the treatment of multiple myeloma, expands Natco’s footprint in the U.S. generics market. The move underscores the company’s focus on affordable cancer therapies and global market penetration.

Show more

Stay Ahead – Explore Now! Coforge Secures Landmark UK Agreement, Eyes Ancillary Revenue Expansion in Next Half-Decade

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement